Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 12024
TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM50571531(Gs 441524 | Gs-441524 | Gs441524 | US20240140975, ...)
Affinity DataEC50:  440nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM50571531(Gs 441524 | Gs-441524 | Gs441524 | US20240140975, ...)
Affinity DataEC50:  430nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670935(US20240140975, Compound A124)
Affinity DataEC50:  250nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670936(US20240140975, Compound A50)
Affinity DataEC50:  230nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670937(US20240140975, Compound A214 | US20240140975, Comp...)
Affinity DataEC50:  110nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670938(US20240140975, Compound A164 | US20240140975, Comp...)
Affinity DataEC50:  240nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670937(US20240140975, Compound A214 | US20240140975, Comp...)
Affinity DataEC50:  100nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670938(US20240140975, Compound A164 | US20240140975, Comp...)
Affinity DataEC50:  270nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670937(US20240140975, Compound A214 | US20240140975, Comp...)
Affinity DataEC50:  110nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM50236025(CHEMBL2016761 | US11149049, No. C2 | US20240140975...)
Affinity DataEC50:  580nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM670943(US20240140975, Compound A151)
Affinity DataEC50:  310nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM50571531(Gs 441524 | Gs-441524 | Gs441524 | US20240140975, ...)
Affinity DataEC50:  480nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Shanghai Institute of Materia Medica

US Patent
LigandPNGBDBM429505(Remdesivir | med.21724, Compound 178 | US202400347...)
Affinity DataEC50:  2.00E+3nMAssay Description:Determining the inhibitory activity of compounds of the present invention on the replication of 2019 novel coronavirus (SARS-CoV-2): Vero E6 cells we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2024
Entry Details
Go to US Patent